Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use
European Patent
25152319.7
Filed on 2025-01-16
25152319.7
Filed on 2025-01-16
VIRUS-LIKE PARTICLES AND METHODS OF USE
US Application 18/975,072
Filed on 2024-12-10
Filed on 2024-12-10
Human Protective Neutralizing and Non-Neutralizing Antibodies and Their Use Against Influenza Viruses
US Application 63/650,342
Filed on 2024-05-21
Filed on 2024-05-21
SARS-CoV-2 VACCINE
US Application 63/678,464
Filed on 2024-08-01
Filed on 2024-08-01
MALARIA PROTEIN NANOPARTICLE VACCINES AND USES THEREOF
US Application 63/695,288
Filed on 2024-09-16
Filed on 2024-09-16
WEST NILE VIRUS NEUTRALIZING MONOCLONAL ANTIBODIES
US Application 63/677,612
Filed on 2024-07-31
Filed on 2024-07-31
RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3
EXPRESSING AVIAN INFLUENZA VIRUS PROTEINS AND USE THEREOF
US Application 63/705,659
Filed on 2024-10-10
Filed on 2024-10-10
Human Monoclonal Antibodies That Broadly Target Coronaviruses
South Korea
10-2024-7030215
Filed on 2024-09-09
10-2024-7030215
Filed on 2024-09-09
Human Monoclonal Antibodies That Broadly Target Coronaviruses
Canada
3251161
Filed on 2024-08-09
3251161
Filed on 2024-08-09
Engineered influenza neuraminidase with altered catalytic activity
US Application 63/730,558
Filed on 2024-12-11
Filed on 2024-12-11